Suppr超能文献

相似文献

1
P2RX7 at the Host-Pathogen Interface of Infectious Diseases.
Microbiol Mol Biol Rev. 2021 Jan 13;85(1). doi: 10.1128/MMBR.00055-20. Print 2021 Feb 17.
2
an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.
J Parkinsons Dis. 2024 Nov;14(8):1575-1583. doi: 10.1177/1877718X241296015. Epub 2024 Dec 1.
4
Epidermal growth factor receptor signaling governs the host inflammatory response to invasive aspergillosis.
mBio. 2024 Dec 11;15(12):e0267124. doi: 10.1128/mbio.02671-24. Epub 2024 Oct 30.
7
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

3
The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation.
Front Immunol. 2024 Apr 22;15:1360140. doi: 10.3389/fimmu.2024.1360140. eCollection 2024.
4
Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function.
Front Immunol. 2024 Mar 11;15:1360342. doi: 10.3389/fimmu.2024.1360342. eCollection 2024.
5
Blocking P2Y2 purinergic receptor prevents the development of lipopolysaccharide-induced acute respiratory distress syndrome.
Front Immunol. 2023 Dec 20;14:1310098. doi: 10.3389/fimmu.2023.1310098. eCollection 2023.
7
Ginsenosides enhance P2X7-dependent cytokine secretion from LPS-primed rodent macrophages.
Purinergic Signal. 2024 Feb;20(1):65-71. doi: 10.1007/s11302-023-09935-0. Epub 2023 Apr 14.
8
The impact of cannabinoids on inflammasome signaling in HIV-1 infection.
NeuroImmune Pharm Ther. 2023 Mar 25;2(1):79-88. doi: 10.1515/nipt-2023-0002. Epub 2023 Feb 23.
9
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1.
Curr Opin Pharmacol. 2023 Apr;69:102358. doi: 10.1016/j.coph.2023.102358. Epub 2023 Feb 27.

本文引用的文献

1
The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?
Scand J Immunol. 2021 Feb;93(2):e12960. doi: 10.1111/sji.12960. Epub 2020 Sep 8.
2
SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7880-7885. doi: 10.26355/eurrev_202007_22293.
3
Targeting the NLRP3 Inflammasome in Severe COVID-19.
Front Immunol. 2020 Jun 23;11:1518. doi: 10.3389/fimmu.2020.01518. eCollection 2020.
5
A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
Br J Pharmacol. 2020 Nov;177(21):4990-4994. doi: 10.1111/bph.15138. Epub 2020 Jul 26.
6
The Role of Nuclear Medicine for COVID-19: Time to Act Now.
J Nucl Med. 2020 Jun;61(6):781-782. doi: 10.2967/jnumed.120.246611. Epub 2020 Apr 17.
10
NLRP3 gain-of-function in CD4 T lymphocytes ameliorates experimental autoimmune encephalomyelitis.
Clin Sci (Lond). 2019 Sep 13;133(17):1901-1916. doi: 10.1042/CS20190506.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验